Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure

doi:10.3748/wjg.v19.i7.1104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8929)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

625

HTML

5935

Figures (1-4)

157

Tables (1-1)

142

Sum=6859

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1064

Download

1006

Sum=2070

Feb 21, 2013 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (113)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 21, 2013; 19(7): 1104-1110
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1104

Full Size Figure Download Figure

Figure 4 Survival rate of patients treated with granulocyte-colony stimulating factor and in controls. G-CSF: Granulocyte-colony stimulating factor.

Citation: Duan XZ, Liu FF, Tong JJ, Yang HZ, Chen J, Liu XY, Mao YL, Xin SJ, Hu JH. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2013; 19(7): 1104-1110
URL: https://www.wjgnet.com/1007-9327/full/v19/i7/1104.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i7.1104